Amgen to Present at the Deutsche Bank 37th Annual Healthcare Conference Read more about Amgen to Present at the Deutsche Bank 37th Annual Healthcare Conference
Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California Read more about Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
Amgen Receives Complete Response Letter From FDA for XGEVA® sBLA for Prevention of Bone Metastases Read more about Amgen Receives Complete Response Letter From FDA for XGEVA® sBLA for Prevention of Bone Metastases
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company Read more about Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Amgen's First Quarter 2012 Revenue Increased 9 Percent To $4.0 Billion And Adjusted Earnings Per Share (EPS) Increased 20 Percent To $1.61 Read more about Amgen's First Quarter 2012 Revenue Increased 9 Percent To $4.0 Billion And Adjusted Earnings Per Share (EPS) Increased 20 Percent To $1.61
A Tribute to George Rathmann, Amgen's Founding CEO (1927-2012) Read more about A Tribute to George Rathmann, Amgen's Founding CEO (1927-2012)
Amgen Announces Webcast of 2012 First Quarter Financial Results Read more about Amgen Announces Webcast of 2012 First Quarter Financial Results
Amgen to Acquire Privately Held KAI Pharmaceuticals Read more about Amgen to Acquire Privately Held KAI Pharmaceuticals
UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis Read more about UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio Read more about Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio
